Last C$2.52 CAD
Change Today +0.01 / 0.40%
Volume 70.9K
As of 3:52 PM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

neptune tech & bioressources (NTB) Snapshot

Open
C$2.51
Previous Close
C$2.51
Day High
C$2.55
Day Low
C$2.50
52 Week High
08/13/13 - C$4.35
52 Week Low
04/7/14 - C$2.41
Market Cap
183.2M
Average Volume 10 Days
85.2K
EPS TTM
C$-0.37
Shares Outstanding
72.7M
EX-Date
07/24/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEPTUNE TECH & BIORESSOURCES (NTB)

Related News

No related news articles were found.

neptune tech & bioressources (NTB) Related Businessweek News

No Related Businessweek News Found

neptune tech & bioressources (NTB) Details

Neptune Technologies & Bioressources Inc., a biotechnology company, focuses on the research, development, and commercialization of products derived from marine biomasses for the nutraceutical and pharmaceutical industries. It produces marine-derived omega-3 polyunsaturated fatty acids, including Neptune Krill Oil (NKO), a dietary supplement for heart, joint, women, and brain health; ECOKRILL Oil (EKO), a krill product; and Neptune Krill Aquatein (NKA), a protein ingredient used in the production of nursing feed for young animals. The company also develops active pharmaceutical ingredients for cardiovascular and neurological diseases; and prescription drugs and medical foods for the safe and effective management of cognitive, behavioral, and neurodegenerative disorders. Neptune Technologies & Bioressources sells its products in Canada, the United States, France, Belgium, Australia, Japan, and other countries. The company was founded in 1925 and is headquartered in Laval, Canada.

10 Employees
Last Reported Date: 01/14/14
Founded in 1925

neptune tech & bioressources (NTB) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: C$231.3K
Chief Financial Officer, Vice President of Ad...
Total Annual Compensation: C$176.9K
Chief Global Strategic Officer
Total Annual Compensation: C$112.7K
Chief Financial Officer of Acasti Pharma
Total Annual Compensation: C$23.6K
Chief Operating Officer of Acasti
Total Annual Compensation: C$19.9K
Compensation as of Fiscal Year 2013.

neptune tech & bioressources (NTB) Key Developments

Neptune Technologies & Bioresources, Inc. Provides Reconstruction Update on Sherbrooke Plant

Neptune Technologies & Bioressources Inc. announced that reconstruction of its Sherbrooke, Quebec, Canada production facility will be completed April 7, 2014. Neptune is currently conducting equipment and safety related tests at the plant and employees are being trained. Preoperational testing will start early April 2014, with actual production commencing upon receipt of all outstanding permits. The corporation continues to work with various government authorities, including those related to workers health & safety and the environment, to obtain all remaining permits to begin operations. Neptune has been actively working with these agencies during the construction process and has cooperated with them to implement their recommendations. The new facility will have the capacity to produce more than 150 metric tons of krill oil annually. In addition, the plant has the required space to allow for a doubling of production capacity in the future, depending on demand.

Neptune Technologies & Bioresources, Inc. Presents at 26th Annual ROTH Conference, Mar-10-2014 05:30 PM

Neptune Technologies & Bioresources, Inc. Presents at 26th Annual ROTH Conference, Mar-10-2014 05:30 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States.

Neptune Appoints John Moretz as Special Advisor and Nominee to Board of Directors

Neptune Technologies & Bioressources Inc. appointed of John Moretz as special advisor to its Board of Directors. Mr. Moretz has also accepted the nomination for election to serve on the corporation's Board of Directors at the next Annual Meeting to be held in 2014, subject to shareholders approval. John Moretz currently serves as CEO and President of Moretz Marketing LLC and is Managing Director for kathy ireland, LLC. In addition, he is the managing director for various real estate entities including LaMoe, LLC and Moretz Mills, LLC. Mr. Moretz spent 39 years in the hosiery industry.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NTB:CN C$2.52 CAD +0.01

NTB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Badger Meter Inc $52.25 USD +0.04
Enzymotec Ltd $19.39 USD -1.00
Itron Inc $35.26 USD -0.27
Targeted Medical Pharma Inc $0.69 USD -0.01
View Industry Companies
 

Industry Analysis

NTB

Industry Average

Valuation NTB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.2x
Price/Book 3.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 7.9x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEPTUNE TECH & BIORESSOURCES, please visit www.neptunebiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.